Advertisement

Family Screening and Genetic Counseling

  • Pál Perge
  • Peter IgazEmail author
Chapter
Part of the Experientia Supplementum book series (EXS, volume 111)

Abstract

In this brief chapter, clinically very important topics of family screening and genetic counseling are discussed that are also pivotal in endocrine genetics. Genetic screening makes possible to diagnose a genetic disease at an early stage or to exclude its presence. Family members have to be screened if a heritable disease is diagnosed. Personal consultation with the patient and the relatives is inevitable in every genetically determined disease. The main function of genetic counseling is the transfer of important pieces of information to the patient about the congenital or later-manifesting diseases. This process via the informed consent should give enough information to the patient and the relatives to make decisions about the disease. Genetic data should be considered as special data; therefore the protection of the personal data and the confidentiality obligation should be prevailed intensively. The chief goal of the genetic counseling is the prevention of the conception or the birth of a person who would suffer from a severe genetic disease and/or to present information of the chance for having an affected descendant. If the prevention is not feasible, the alternative aim is to prevent the development of the consequences or to moderate its severity. Genetic counseling has important ethical aspects such as prenatal genetic investigations; hereditary, but treatable, nonlethal diseases; and genetic diseases that manifest late, predominantly in the adulthood.

Keywords

Genetic screening Heritable disease Genetic counseling Prevention Ethical aspects 

Notes

Acknowledgments

Supported by the Higher Education Institutional Excellence Programme of the Ministry of Human Capacities in Hungary, within the framework of the molecular biology thematic program of the Semmelweis University.

References

  1. Benn P, Borrell A, Chiu RWK et al (2015) Position statement from the Chromosome Abnormality Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis. Prenat Diagn 35:725–734.  https://doi.org/10.1002/pd.4608 CrossRefPubMedGoogle Scholar
  2. Gilchrist DM (2002) Medical genetics: 3. An approach to the adult with a genetic disorder. CMAJ 167:1021–1029PubMedPubMedCentralGoogle Scholar
  3. Grover S (2003) The psychological dimension of informed consent: dissonance processes in genetic testing. J Genet Couns 12:389–403CrossRefGoogle Scholar
  4. Hodgson JM, Gillam LH, Sahhar MA, Metcalfe SA (2010) “Testing times, challenging choices”: an Australian study of prenatal genetic counseling. J Genet Couns 19:22–37.  https://doi.org/10.1007/s10897-009-9248-6 CrossRefPubMedGoogle Scholar
  5. Jackson-Cook C, Pandya A (1995) Strategies and logistical requirements for efficient testing in genetic disease. Clin Lab Med 15:839–857CrossRefGoogle Scholar
  6. McCabe LL, McCabe ERB (2004) Genetic screening: carriers and affected individuals. Annu Rev Genomics Hum Genet 5:57–69.  https://doi.org/10.1146/annurev.genom.5.061903.175941 CrossRefPubMedGoogle Scholar
  7. Ormond KE, Laurino MY, Barlow-Stewart K et al (2018) Genetic counseling globally: where are we now? Am J Med Genet C Semin Med Genet 178:98–107.  https://doi.org/10.1002/ajmg.c.31607 CrossRefPubMedPubMedCentralGoogle Scholar
  8. Pletcher BA, Toriello HV, Noblin SJ et al (2007) Indications for genetic referral: a guide for healthcare providers. Genet Med 9:385–389. https://doi.org/10.1097GIM.0b013e318064e70c CrossRefGoogle Scholar
  9. Raymond VM, Gray SW, Roychowdhury S et al (2016) Germline findings in tumor-only sequencing: points to consider for clinicians and laboratories: Table 1. J Natl Cancer Inst 108:djv351.  https://doi.org/10.1093/jnci/djv351 CrossRefPubMedGoogle Scholar
  10. Resta R, Biesecker BB, Bennett RL et al (2006) A new definition of genetic counseling: National Society of Genetic Counselors’ Task Force report. J Genet Couns 15:77–83.  https://doi.org/10.1007/s10897-005-9014-3 CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.2nd Department of Internal Medicine, Faculty of MedicineSemmelweis UniversityBudapestHungary
  2. 2.MTA-SE Molecular Medicine Research GroupHungarian Academy of Sciences and Semmelweis UniversityBudapestHungary

Personalised recommendations